Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zhi‑Yu Guan
Combination of Pembrolizumab and 125I Attenuates the Aggressiveness of Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Related publications
FADD Protein Release Mirrors the Development and Aggressiveness of Human Non-Small Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
New PDL1 Inhibitors for Non-Small Cell Lung Cancer: Focus on Pembrolizumab
OncoTargets and Therapy
Oncology
Pharmacology
Pcn4 - Effectiveness and Safety of Pembrolizumab in Advanced or Metastatic Non-Small Cell Lung Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pembrolizumab‐induced Secondary Sclerosing Cholangitis in a Non‐small Cell Lung Cancer Patient
Respirology Case Reports
Pulmonary
Respiratory Medicine
Combination Studies With Gemcitabine in the Treatment of Non-Small-Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Pharmacoeconomic Study of Pembrolizumab and Nivolumab in the Second Line of Therapy of Advanced Non-Small Cell Lung Cancer
Effective Pharmacotherapy
Pembrolizumab-Induced Obstructive Bronchiolitis in a Patient With Stage IV Non-Small-Cell Lung Cancer
Current Oncology
Oncology
Non-Small Cell Lung Cancer
OPN Promotes the Aggressiveness of Non-Small-Cell Lung Cancer Cells Through the Activation of the RON Tyrosine Kinase
Scientific Reports
Multidisciplinary
